Both genetic inhibition of mitochondrial ROS production and pharmacological treatment of RyR2 leakage prevented AF indicating that alterations of RyR2 and mitochondrial ROS generation form a vicious cycle in the development of AF23. Here, RYR2 is linked to atrial fibrillation.